Literature DB >> 22576637

Postmortem findings of malignant pleural mesothelioma: a two-center study of 318 patients.

Rhian S Finn1, Fraser J H Brims2, Arjun Gandhi3, Nola Olsen4, A William Musk5, Nick A Maskell6, Y C Gary Lee7.   

Abstract

BACKGROUND: Malignant pleural mesothelioma (MPM) is an incurable cancer with a rising incidence. MPM is often perceived as a locally invasive cancer, and the exact cause of death is poorly understood.This two-center study describes the anatomic features of patients with MPM at postmortem.
METHODS: The Western Australia Mesothelioma Registry (Australia) and Coroner’s Office reports from the Avon region (England) were interrogated for the postmortem records of confirmed mesothelioma cases.
RESULTS: Postmortem records of 318 patients with pleural mesothelioma (169 from Western Australia and 149 from Avon) were identified. Most patients (91.5%) were men (mean age, 68.4 ± 11.5 years), and MPM was right-sided in 55.3%. Extrapleural dissemination of tumor was found in 87.7% of cases and lymph node involvement in 53.3%. Tumor dissemination in extra thoracicsites was common (55.4% of patients), and almost all organs were involved, including liver(31.9%), spleen (10.8%), thyroid (6.9%), and the brain (3.0%). Pulmonary emboli were found in 6% of cases and considered as directly contributing to death in 13 patients (4.1%). The precise cause of death could only be determined in 63 (19.8%) cases even after postmortem. The BMI was significantly lower in cases that had no identifiable anatomic cause of death at postmortem(18.8 ± 4.3 vs 21.0 ± 4.7, P = .034).
CONCLUSIONS: In this largest, to our knowledge, postmortem series on MPM, extrathoracic dissemination of mesothelioma was common and often under recognized. No anatomic cause of death was identified in the majority of patients even at autopsy, raising the possibility of physiologic and metabolic causes of death.

Entities:  

Mesh:

Year:  2012        PMID: 22576637     DOI: 10.1378/chest.11-3204

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  24 in total

1.  Brain metastases in malignant pleural mesothelioma.

Authors:  Tomoko Yamagishi; Nobukazu Fujimoto; Yosuke Miyamoto; Michiko Asano; Yasuko Fuchimoto; Sae Wada; Kenichi Kitamura; Shinji Ozaki; Hideyuki Nishi; Takumi Kishimoto
Journal:  Clin Exp Metastasis       Date:  2015-11-30       Impact factor: 5.150

Review 2.  Malignant pleural mesothelioma: an update on diagnosis and treatment options.

Authors:  Sanjana Kondola; David Manners; Anna K Nowak
Journal:  Ther Adv Respir Dis       Date:  2016-02-12       Impact factor: 4.031

Review 3.  Malignant pleural mesothelioma: predictors and staging.

Authors:  William G Richards
Journal:  Ann Transl Med       Date:  2017-06

4.  Rare presentation of a localised malignant pleural mesothelioma with cranial metastasis.

Authors:  Gulhan Ertan; Abdulkadir Eren; Sila Ulus
Journal:  BMJ Case Rep       Date:  2016-10-04

Review 5.  Mesothelioma: Scientific clues for prevention, diagnosis, and therapy.

Authors:  Michele Carbone; Prasad S Adusumilli; H Richard Alexander; Paul Baas; Fabrizio Bardelli; Angela Bononi; Raphael Bueno; Emanuela Felley-Bosco; Francoise Galateau-Salle; David Jablons; Aaron S Mansfield; Michael Minaai; Marc de Perrot; Patricia Pesavento; Valerie Rusch; David T Severson; Emanuela Taioli; Anne Tsao; Gavitt Woodard; Haining Yang; Marjorie G Zauderer; Harvey I Pass
Journal:  CA Cancer J Clin       Date:  2019-07-08       Impact factor: 508.702

6.  Unusual Contiguous Soft Tissue Spread of Advanced Malignant Mesothelioma Detected by FDG PET/CT.

Authors:  Yuyang Zhang; Jamie Edwards; Hadyn Williams; Zhonglin Hao; Samir Khleif; Darko Pucar
Journal:  Nucl Med Mol Imaging       Date:  2016-06-06

Review 7.  Malignant mesothelioma and central nervous system metastases. Report of two cases, pooled analysis, and systematic review.

Authors:  Andrew C Miller; Markku Miettinen; David S Schrump; Raffit Hassan
Journal:  Ann Am Thorac Soc       Date:  2014-09

8.  Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.

Authors:  Craig W Menges; Yuwaraj Kadariya; Deborah Altomare; Jacqueline Talarchek; Erin Neumann-Domer; Yue Wu; Guang-Hui Xiao; Irina M Shapiro; Vihren N Kolev; Jonathan A Pachter; Andres J Klein-Szanto; Joseph R Testa
Journal:  Cancer Res       Date:  2013-12-26       Impact factor: 12.701

9.  Cerebral Metastasis of a Malignant Pleural Mesothelioma: A Case Report and Review of the Literature.

Authors:  Aswin Chari; Angelos G Kolias; Kieren Allinson; Thomas Santarius
Journal:  Cureus       Date:  2015-01-15

10.  Metastatic mesothelioma to the thyroid.

Authors:  Sarika N Rao; Archana Swami; Ashraf Khan; Madhavi Toke; Giles Whalen; Andrew Fischer; Mira Sofia Torres
Journal:  Cytojournal       Date:  2014-05-22       Impact factor: 2.091

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.